Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
LXRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.79%171.561.2%$575.26m
CELGCelgene Corporation
-0.75%88.951.2%$554.24m
GILDGilead Sciences, Inc.
-0.99%73.700.9%$441.10m
BIIBBiogen Inc.
-1.13%263.021.2%$436.72m
REGNRegeneron Pharmaceuticals, Inc.
-0.50%314.252.7%$242.24m
INCYIncyte Corporation
-0.90%68.432.5%$236.48m
VRTXVertex Pharmaceuticals Incorporated
-0.88%158.151.9%$224.32m
ALXNAlexion Pharmaceuticals, Inc.
-3.54%107.782.0%$215.70m
NKTRNektar Therapeutics
-4.37%86.216.0%$196.49m
ILMNIllumina, Inc.
-0.50%244.603.5%$185.23m
AAgilent Technologies, Inc.
-0.63%67.541.5%$152.87m
ALNYAlnylam Pharmaceuticals, Inc
1.34%97.489.8%$137.98m
BLUEBluebird Bio, Inc.
0.00%170.5015.8%$135.45m
EXASExact Sciences Corporation
1.54%47.5225.7%$108.85m
BMRNBioMarin Pharmaceutical Inc.
-1.58%82.304.4%$107.66m

Company Profile

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It also offers programs in clinical development for diabetes, irritable bowel syndrome, and carcinoid syndrome. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.